Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients
NCT01169571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 373
Last updated 2015-07-24
Summary
The objective of this study is to characterize the hemodynamic effects of Precedex (dexmedetomidine (DEX)) during 3 loading-dose paradigms in mechanically ventilated post-surgical subjects in an intensive care setting.
Conditions
- Intensive Care Unit
Interventions
- DRUG
-
Dexmedetomidine
Sponsors & Collaborators
-
Hospira, now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
NCT00747721 ·Status: COMPLETED ·Phase: PHASE1
-
Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion
NCT00538616 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers
NCT04659642 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Self-management of Sedative Therapy by Ventilated Patients
NCT02819141 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients
NCT04358627 ·Status: UNKNOWN
-
Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure
NCT01076816 ·Status: TERMINATED ·Phase: PHASE3
-
Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
NCT01059929 ·Status: TERMINATED ·Phase: PHASE4
-
Population Pharmacokinetics of Dexmedetomidine in ICU Patients
NCT00714857 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00481312 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation
NCT00839605 ·Status: COMPLETED
-
Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19
NCT04413864 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults
NCT06259565 ·Status: RECRUITING ·Phase: PHASE3
-
Dexmedetomidine Versus Midazolam for Facilitating Extubation
NCT00744380 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine for Prolonged Sedation in PICUs
NCT03760978 ·Status: COMPLETED
-
Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients
NCT04730375 ·Status: COMPLETED ·Phase: PHASE2
-
Early Sedation With Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients
NCT06251375 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Impact of a Single Dexmedetomidine Bolus on Intraoperative Sevoflurane Consumption (DEXHALE)
NCT05615194 ·Status: UNKNOWN ·Phase: NA
-
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
NCT00318955 ·Status: COMPLETED ·Phase: PHASE4
-
Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients
NCT01606852 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of Dexmedetomidine in Septic Patients
NCT01976754 ·Status: COMPLETED ·Phase: NA
-
Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects
NCT00526760 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough
NCT03126422 ·Status: UNKNOWN ·Phase: PHASE1
-
Risk Prediction of Dexmedetomidine-associated Hemodynamic Instability
NCT03285087 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Dexmedetomidine for Continuous Sedation
NCT00226785 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine
NCT05993975 ·Status: COMPLETED ·Phase: PHASE4